Skip to main content
Shaily Engineering Plastics Ltd. logo

Shaily Engineering Plastics Ltd. — Investor Relations & Filings

Ticker · SHAILY ISIN · INE151G01028 LEI · 335800T1LWSQ3UCPMB53 BSE.NS Manufacturing
Open in API
Filings indexed 845 across all filing types
Latest filing 2025-11-08 Regulatory Filings
Country IN India
Listing BSE.NS SHAILY

About Shaily Engineering Plastics Ltd.

https://shaily.com/

Shaily Engineering Plastics Ltd. is a precision injection molding company specializing in the manufacture of high-complexity plastic components and assemblies. The company provides end-to-end solutions encompassing product design, mold manufacturing, injection molding, and post-molding assembly. Its core expertise lies in processing high-performance engineering polymers for critical applications. Shaily serves a diverse range of global markets, including healthcare, where it produces sophisticated drug delivery devices such as insulin pens and inhalers. Additionally, the company is a significant supplier to the home furnishings sector and provides components for the FMCG, automotive, and industrial segments. With a focus on technical excellence and quality assurance, the firm operates advanced manufacturing facilities equipped with robotic automation and cleanroom environments to meet stringent international standards.

Recent filings

Filing Released Lang Actions
Submission of Unaudited Standalone and Consolidated Financial Results for the half year and quarter ended on September 30, 2025
Regulatory Filings
2025-11-08 English
Agreements
Capital/Financing Update Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding the granting of an unsecured loan to a wholly owned subsidiary. It references compliance with SEBI Listing Regulations and provides detailed terms of the loan agreement, including parties involved, loan amount, interest rate, and related party transaction status. The content is an announcement of a financing transaction rather than a financial report or earnings release. It does not contain financial statements or management discussion but focuses on capital/financing update information. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length (6019 characters) and detailed loan information support this classification with high confidence.
2025-10-31 English
Intimation of granting of Inter Coprorate Loan to Shaily Innovations FZCO, Dubai, UAE a Wholly Owned Subsidiary of the Company
Regulatory Filings
2025-10-31 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an announcement of an upcoming earnings call scheduled for November 10, 2025, to discuss the operational and financial performance for the quarter and half year ended September 30, 2025. It includes details such as date, time, dial-in numbers, and participants, but does not contain any actual financial results or substantive financial data. The document is relatively short (2097 characters) and serves as an invitation or notice rather than the transcript or report itself. Therefore, it fits the definition of a Call Transcript (CT) only if it contained the full transcript, but since this is only an announcement of the call, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement under SEBI Listing Regulations. However, given the specific category options, the best fit is Call Transcript (CT) because the document is about the earnings call event itself, and the category includes full text transcripts of company conference calls. But since this is only an announcement and not the transcript, the correct classification is Regulatory Filings (RNS).
2025-10-31 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board Meeting scheduled for November 8, 2025. The purpose of the meeting includes considering and approving unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. It also mentions the closure of the trading window in compliance with insider trading regulations. The document references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities, specifically board meeting intimation. The document is short (1971 characters) and serves as an announcement of a board meeting and related compliance matters, not the financial results report itself. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement about an upcoming board meeting and financial results approval, not the actual financial report or detailed management information.
2025-10-31 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.